V P Gupta Selected Research

Metabolic Syndrome (Dysmetabolic Syndrome X)

3/2012	Persistent high prevalence of cardiovascular risk factors in the urban middle class in India: Jaipur Heart Watch-5.
11/2010	Cardiovascular risk according to educational status in India.
10/2007	Fasting glucose and cardiovascular risk factors in an urban population.
9/2007	Body-mass index, waist-size, waist-hip ratio and cardiovascular risk factors in urban subejcts.
7/2007	Trends in prevalence of coronary risk factors in an urban Indian population: Jaipur Heart Watch-4.
11/2004	High prevalence of multiple coronary risk factors in Punjabi Bhatia community: Jaipur Heart Watch-3.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

V P Gupta Research Topics

Disease

11	Hypertension (High Blood Pressure) 12/2012 - 05/2001
10	Obesity 03/2012 - 01/2002
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2012 - 11/2004
5	Overweight 12/2012 - 11/2004
3	Hypercholesterolemia 11/2010 - 01/2002
3	Abdominal Obesity 07/2007 - 07/2003
2	Coronary Disease (Coronary Heart Disease) 11/2004 - 05/2001
2	Dyslipidemias (Dyslipidemia) 01/2002 - 05/2001
1	Weight Loss (Weight Reduction) 12/2018
1	Capillary Hemangioma 07/2013
1	Pterygium 04/2013
1	Poisoning 10/2012
1	Hypertriglyceridemia 03/2012
1	Neurocysticercosis 01/2012
1	Capsule Opacification 01/2012
1	Epilepsy (Aura) 01/2012
1	Amebiasis (Amoebiasis) 01/2009
1	Giardiasis 01/2009
1	Trichomonas Infections 01/2009
1	Bacterial Vaginosis 01/2009
1	Blindness (Hysterical Blindness) 07/2008
1	Entropion 07/2008
1	Low Vision (Subnormal Vision) 07/2008
1	Growth Disorders 04/2006
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2006
1	Malnutrition (Nutritional Deficiencies) 04/2006
1	Morbid Obesity 11/2004
1	Atherosclerosis 07/2003
1	Insulin Resistance 07/2003
1	Congenital Abnormalities (Deformity) 01/2003
1	Wounds and Injuries (Trauma) 01/2003

Drug/Important Bio-Agent (IBA)

8	HDL CholesterolIBA 03/2012 - 05/2001
6	CholesterolIBA 03/2012 - 05/2001
6	Triglycerides (Triacylglycerol)IBA 10/2007 - 01/2002
4	LipidsIBA 12/2012 - 05/2001
2	Glucose (Dextrose)FDA LinkGeneric 10/2007 - 07/2003
2	LDL CholesterolIBA 05/2003 - 05/2001
1	Sericins (Sericin)IBA 12/2018
1	Bleomycin (Blenoxane)FDA LinkGeneric 07/2013
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 04/2013
1	InsecticidesIBA 10/2012
1	Indicators and Reagents (Reagents)IBA 01/2012
1	secnidazoleIBA 01/2009
1	Pharmaceutical PreparationsIBA 01/2009
1	Retinaldehyde (Retinal)IBA 07/2008
1	SugarsIBA 04/2006
1	GurIBA 04/2006
1	FatsIBA 04/2006
1	OilsIBA 04/2006
1	oxidized low density lipoproteinIBA 05/2003

Therapy/Procedure

1	Intraperitoneal Injections 10/2012
1	Intraocular Lenses (Intraocular Lens) 01/2012
1	Corneal Transplantation (Keratoplasty) 07/2008
1	Eyeglasses (Spectacles) 01/2003